Therapeutic area intelligence for Electrolyte Replenisher with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals: 2
Catalysts: 0
Companies: 0

Companies

No related entities indexed yet.

Assets

ASPIRO →

FDA →

Recent signals(2)

RegulatoryJuly 27, 2026

FDA Grants Approval for Sodium Bicarbonate Application ANDA220788

The FDA has granted approval for the sodium bicarbonate application ANDA220788 submitted by ASPIRO.

RegulatoryJuly 16, 2026

FDA Grants Approval for Sodium Bicarbonate ANDA219089 by Milla Pharms

The FDA has granted approval for the Abbreviated New Drug Application (ANDA) 219089 for Sodium Bicarbonate submitted by Milla Pharms.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Metabolic Disorders →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.